Dear Colleague,

On behalf of Immuno-oncology Society of India, we are pleased to invite you for the “3rd Annual Congress of I-OSI”. This meeting will be held virtually from 8th - 10th October 2021.

The theme of this year's conference is "Precision Immuno-Oncology : Choosing wisely".

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them. According to the report, there was a 22 percent increase of I-O drugs in the development pipeline from 2019 to 2020. Overall, this growth amounts to a 233 percent increase from the first CRI I-O Landscape report published just three years ago.

At this conference, Immuno-oncology International and National expert will provide up-to-date data insights supporting the use of precision immunotherapies, including immune checkpoint inhibitors, cellular therapies, and discusses investigational immuno-oncology pathways, putative targets for novel therapies, and current and emerging prognostic biomarkers to inform clinical treatment decisions.

I-OSI is committed to continuously deliver top-notch content and bring all experts under the same roof. There will be an Online Preparatory Workshop which is aimed to warm up the conference audience prior to the main conference. This conference will help connect academics, industry experts, and professionals interested in IO. Keynote lectures, engaging panels and ample time for audience Q&A are regular feature of I-OSI events.

The organising committee wishes to start connecting with all the oncologists to kick-start the discussion and help build a more inclusive and engaging I-OSICON 2021.

We look forward to making this a great learning opportunity for all participants.


Dr Jyoti Bajpai,
Consultant Medical Oncologist
Tata Memorial Centre
Mumbai, India